Liabilities / Assets
60th percentile
Higher debt load relative to assets than 60% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.09x
Liabilities / Revenue
54th percentile
Higher debt load relative to revenue than 54% of similar nonprofits.
Net Margin
18th percentile
Higher net margin than 18% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
12th percentile
Faster asset growth than 12% of similar nonprofits.
Revenue Growth
29th percentile
Faster revenue growth than 29% of similar nonprofits.
Balance Sheet
Assets
Down$341,419
Down $60,023 (-15%) from 2015
Net Assets
Down$309,820
Down $91,622 (-23%) from 2015
Liabilities
Up$31,599
Up $31,599 from 2015
Revenue And Expenses
Revenue
Down$629,307
Down $46,891 (-6.9%) from 2015
Expenses
Up$720,929
Up $157,518 (+28%) from 2015
Net Income
Down-$91,622
Down $204,409 (-181%) from 2015
Historical Trend
Filing Detail Status
This 2016 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2016 to Dec 31, 2016
Mission and Program Overview
Mission
Raise funds for leukemia and lymphoma research and for other charitable nonprofit organizations.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2016 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $341,419
- Liabilities
- $31,599
- Net assets
- $309,820
- Revenue
- $629,307
- Expenses
- $720,929
- Net income
- -$91,622